Analyst Price Targets — GL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 9:47 am | Paul Newsome | Piper Sandler | $200.00 | $178.99 | TheFly | Globe Life price target raised to $200 from $175 at Piper Sandler |
| July 10, 2026 11:48 am | — | Jefferies | $166.00 | $178.86 | TheFly | Globe Life price target raised to $166 from $147 at Jefferies |
| May 26, 2026 10:47 am | — | Piper Sandler | $175.00 | $156.28 | TheFly | Globe Life price target raised to $175 from $167 at Piper Sandler |
| May 21, 2026 12:05 pm | — | Morgan Stanley | $181.00 | $155.30 | TheFly | Globe Life price target raised to $181 from $176 at Morgan Stanley |
| April 24, 2026 1:31 pm | Mark Hughes | Truist Financial | $185.00 | $153.55 | TheFly | Globe Life price target raised to $185 from $180 at Truist |
| February 18, 2026 1:16 pm | — | Evercore ISI | $157.00 | $144.86 | TheFly | Globe Life price target raised to $157 from $155 at Evercore ISI |
| December 15, 2025 1:43 pm | Bob Huang | Morgan Stanley | $176.00 | $140.82 | TheFly | Globe Life price target lowered to $176 from $177 at Morgan Stanley |
| November 21, 2025 1:27 pm | John Barnidge | Piper Sandler | $167.00 | $133.61 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Globe Life (GL) |
| October 24, 2025 1:15 pm | Mark Hughes | Truist Financial | $158.00 | $134.49 | TheFly | Globe Life price target raised to $158 from $150 at Truist |
| October 7, 2025 3:42 pm | Bob Huang | Morgan Stanley | $179.00 | $134.91 | TheFly | Globe Life price target raised to $179 from $171 at Morgan Stanley |
Latest News for GL
Algert Global LLC reduced its stake in shares of Globe Life Inc. (NYSE: GL) by 49.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 35,637 shares of the company's stock after selling 34,510 shares during the quarter. Algert
Bank of Nova Scotia purchased a new position in shares of Globe Life Inc. (NYSE: GL) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 31,404 shares of the company's stock, valued at approximately $5,611,000. A number of other hedge
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Globe Life (NYSE: GL - Get Free Report) and Fairfax Financial (OTCMKTS:FRFHF - Get Free Report) are both large-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Dividends Globe Life pays an annual dividend
GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.